Cited by 2,170Pluripotent Stem Cells ResearchTissue Engineering and Regenerative MedicineLiver physiology and pathology

Vascularized and functional human liver from an iPSC-derived organ bud transplant

Takebe, Takanori, Sekine, Keisuke, Enomura, Masahiro, Koike, Hiroyuki, Kimura, Masaki, Ogaeri, Takunori, Zhang, Ran-Ran, Ueno, Yasuharu +5 more·2013·Nature

Abstract

A critical shortage of donor organs for treating end-stage organ failure highlights the urgent need for generating organs from human induced pluripotent stem cells (iPSCs). Despite many reports describing functional cell differentiation, no studies have succeeded in generating a three-dimensional vascularized organ such as liver. Here we show the generation of vascularized and functional human liver from human iPSCs by transplantation of liver buds created in vitro (iPSC-LBs). Specified hepatic cells (immature endodermal cells destined to track the hepatic cell fate) self-organized into three-dimensional iPSC-LBs by recapitulating organogenetic interactions between endothelial and mesenchymal cells. Immunostaining and gene-expression analyses revealed a resemblance between in vitro grown iPSC-LBs and in vivo liver buds. Human vasculatures in iPSC-LB transplants became functional by connecting to the host vessels within 48 hours. The formation of functional vasculatures stimulated the maturation of iPSC-LBs into tissue resembling the adult liver. Highly metabolic iPSC-derived tissue performed liver-specific functions such as protein production and human-specific drug metabolism without recipient liver replacement. Furthermore, mesenteric transplantation of iPSC-LBs rescued the drug-induced lethal liver failure model. To our knowledge, this is the first report demonstrating the generation of a functional human organ from pluripotent stem cells. Although efforts must ensue to translate these techniques to treatments for patients, this proof-of-concept demonstration of organ-bud transplantation provides a promising new approach to study regenerative medicine.

Integrity signals

Registry

Crossref · 10.1038/nature12271

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Drug screening with organoids can provide connections between genetic mutations and drug responses.

    “Since organoids can maintain the genomic profile of the parent tissue158, drug screening can be used to provide connections between genetic mutations and drug responses37,154,159.”

    From Organoids (2022) · cites this paper as [37]

  • These liver progenitors provide a fertile venue for subsequent liver maturation efforts and, perhaps, the assembly of enhanced 3D liver "organoids".

    “Thus, these liver progenitors provide a fertile venue for subsequent liver maturation efforts and, perhaps, the assembly of enhanced 3D liver “organoids” (Camp et al., 2017; Ogawa et al., 2013; Takebe et al., 2013).”

    From A Roadmap for Human Liver Differentiation from Pluripotent Stem Cells (2018) · cites this paper as Takebe et al., 2013

The citation lists haven’t been fetched yet

References 25 · Cited by 2,170

Authors
Takebe, T., Sekine, K., Enomura, M., Koike, H., Kimura, M., Ogaeri, T., Zhang, R.-R., Ueno, Y., Zheng, Y.-W., Koike, N., Aoyama, S., Adachi, Y., & Taniguchi, H.
Affiliations
  • Yokohama City University (JP)
  • Seirei Sakura Citizen Hospital (JP)
  • Sekisui Medical (Japan) (JP)
  • Advanced Medical Research Center, Yokohama City University (JP)
Corresponding author
  • Takebe, Takanori
  • Taniguchi, Hideki
Venue
Nature
Published
2013-07-03
Volume
499
Issue
7459
Pages
481-484
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W2000151960
Cited by
2,170
References
25
Citations by year
2026: 123 · 2025: 155 · 2024: 179 · 2023: 181 · 2022: 166 · 2021: 211 · 2020: 181 · 2019: 161 · 2018: 174 · 2017: 158 · 2016: 166 · 2015: 128 · 2014: 137 · 2013: 45
FWCI
71.12
Type
journal article
Language
en
Open access
closed
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Funders
Japan Society for the Promotion of Science (24659593, 24689052, 25253079, 24659785, 25461956)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords
induced pluripotent stem cells, liver regeneration, drug-induced liver failure, drug metabolism, immunodeficient mice, regenerative medicine
MeSH terms
Animals, Cell Differentiation, Humans, Liver, Mesoderm, Liver Transplantation, Liver Failure, Cell Lineage, Gene Expression Profiling, Endothelial Cells, Regenerative Medicine, Tissue Culture Techniques, Mice, Chemical and Drug Induced Liver Injury, Induced Pluripotent Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review